Evidence map›Paper›PMID 22581304›Full record

ReviewEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2012

The effect of biomaterials and antifungals on biofilm formation by Candida species: a review.

M Cuéllar-Cruz, A Vega-González, B Mendoza-Novelo, E López-Romero, E Ruiz-Baca, M A Quintanar-Escorza, J C Villagómez-Castro

Abstract readReview
PubMed Publisher
In one paragraph

Review in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 81 citations in OpenAlex.

  1. Biofilm-related characteristics ofFrontiers in cellular and infection microbiology · 2026
    Article
  2. Article
  3. Investigation of antifungal and antibiofilm activities of green synthesized silver nanoparticles against Candida glabrata.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Fungal biofilms: From bench to bedside.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2018
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

M Cuéllar-CruzCentro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco, A.C. (CIATEJ), Unidad de Biotecnología Médica y Farmacéutica, Av. Normalistas #800, Col. Colinas de la Normal, C.P. 44270 Guadalajara, Jalisco, México. cuellarmay@yahoo.com.mx
A Vega-González
B Mendoza-Novelo
E López-Romero
E Ruiz-Baca
M A Quintanar-Escorza
J C Villagómez-Castro
Universidad de Guanajuato · MXUniversidad Juárez del Estado de Durango · MXCentro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Candida albicans, C. glabrata, C. parapsilosis, and C. tropicalis are able to form biofilms on virtually any biomaterial implanted in a human host. Biofilms are a primary cause of mortality in immunocompromised and hospitalized patients, as they cause recurrent and invasive candidiasis, which is difficult to eradicate. This is due to the fact that the biofilm cells show high resistance to antifungal treatments and the host defense mechanisms, and exhibit an excellent ability to adhere to biomaterials. Elucidation of the mechanisms of antifungal resistance in Candida biofilms is of unquestionable importance; therefore, this review analyzes both the chemical composition of biomaterials used to fabricate the medical devices, as well as the Candida genes and proteins that confer drug resistance.

Indexed as

BiofilmsAntifungal AgentsBiocompatible MaterialsCandidaCandidiasis, InvasiveCell AdhesionCell MembraneDrug Resistance, FungalFluconazoleFungal ProteinsGenes, FungalHumansMembrane Transport ProteinsProstheses and ImplantsAntifungal AgentsBiocompatible MaterialsCDR1 protein, Candida albicansFluconazoleFungal ProteinsMembrane Transport Proteins

Identifiers

PMID22581304
OpenAlexW2008463431

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.